ID

40274

Descripción

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01612286

Link

https://clinicaltrials.gov/show/NCT01612286

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/3/20 27/3/20 - Sarah Riepenhausen
Titular de derechos de autor

Zhejiang Cancer Hospital

Subido en

27 de marzo de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Nasopharyngeal Carcinoma NCT01612286

Eligibility Nasopharyngeal Carcinoma NCT01612286

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
Descripción

metastatic NPC, recent radiotherapy of NPC, recent chemoradiotherapy of NPC

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2931822
UMLS CUI [1,2]
C0027627
UMLS CUI [2,1]
C0332185
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C2931822
UMLS CUI [3,1]
C0332185
UMLS CUI [3,2]
C0436307
UMLS CUI [3,3]
C2931822
have measurable lesions
Descripción

measurable disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
no dysfunction of the major organs
Descripción

absent dysfunction of major organs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0178784
UMLS CUI [1,3]
C0205164
UMLS CUI [1,4]
C3887504
can understand this study and give a signed informed consent certificates
Descripción

comprehension of study protocol, informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0021430
without a history of allergic reaction to the biological agents
Descripción

medical history, absent allergic reagents to biological agents

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C1527304
UMLS CUI [1,3]
C0005515
UMLS CUI [1,4]
C0332197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women; women of child-bearing age without contraception
Descripción

pregnancy, breast-feeding, female of child-bearing age with absent contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C1960468
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0700589
with a serious infection or dysfunction of the major organs
Descripción

serious dysfunction of major organs, serious infection of major organs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205404
UMLS CUI [1,2]
C3887504
UMLS CUI [1,3]
C0178784
UMLS CUI [1,4]
C0205164
UMLS CUI [2,1]
C0205404
UMLS CUI [2,2]
C3714514
UMLS CUI [2,3]
C0178784
UMLS CUI [2,4]
C0205164
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
Descripción

recent other cancer treatment with pharmaceutical preparations

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0332185
UMLS CUI [1,4]
C0013227
allergic to the escherichia coli preparations
Descripción

hypersensitivity to Escherichia coli pharmaceutical preparations

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014834
UMLS CUI [1,3]
C0013227
cann't understand this study and give a signed informed consent certificates
Descripción

absent comprehension of study protocol, absent informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0332197

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01612286

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
metastatic NPC, recent radiotherapy of NPC, recent chemoradiotherapy of NPC
Item
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
boolean
C2931822 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0332185 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C2931822 (UMLS CUI [2,3])
C0332185 (UMLS CUI [3,1])
C0436307 (UMLS CUI [3,2])
C2931822 (UMLS CUI [3,3])
measurable disease
Item
have measurable lesions
boolean
C1513041 (UMLS CUI [1])
absent dysfunction of major organs
Item
no dysfunction of the major organs
boolean
C0332197 (UMLS CUI [1,1])
C0178784 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
C3887504 (UMLS CUI [1,4])
comprehension of study protocol, informed consent
Item
can understand this study and give a signed informed consent certificates
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
medical history, absent allergic reagents to biological agents
Item
without a history of allergic reaction to the biological agents
boolean
C0262926 (UMLS CUI [1,1])
C1527304 (UMLS CUI [1,2])
C0005515 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
pregnancy, breast-feeding, female of child-bearing age with absent contraception
Item
pregnant or lactating women; women of child-bearing age without contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C1960468 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
serious dysfunction of major organs, serious infection of major organs
Item
with a serious infection or dysfunction of the major organs
boolean
C0205404 (UMLS CUI [1,1])
C3887504 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0205404 (UMLS CUI [2,1])
C3714514 (UMLS CUI [2,2])
C0178784 (UMLS CUI [2,3])
C0205164 (UMLS CUI [2,4])
recent other cancer treatment with pharmaceutical preparations
Item
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
boolean
C0920425 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,4])
hypersensitivity to Escherichia coli pharmaceutical preparations
Item
allergic to the escherichia coli preparations
boolean
C0020517 (UMLS CUI [1,1])
C0014834 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
absent comprehension of study protocol, absent informed consent
Item
cann't understand this study and give a signed informed consent certificates
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial